Medications as asthma triggers

Immunology and Allergy Clinics of North America

Volumn 25, Issue 1, 2005, Pages 169-190

  Covar, Ronina A ^a   MacOmber, Beth A ^a   Szefler, Stanley J ^a  

^a Department of Pediatrics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ACETYLSALICYLIC ACID; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CELECOXIB; DICLOFENAC; ETODOLAC; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; MECLOFENAMATE SODIUM; MEFENAMIC ACID; MELOXICAM; METOPROLOL; NABUMETONE; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OXAPROZIN; PARACETAMOL; PINDOLOL; PIROXICAM; ROFECOXIB; SALSALATE; SULINDAC; TIMOLOL; TOLMETIN; UNINDEXED DRUG;

ALLELE; ASTHMA; CLINICAL FEATURE; GENOTYPE; HUMAN; MEDICAL RECORD; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTHMA; HUMANS; PREVALENCE;

EID: 9644291605     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2004.09.009     Document Type: Review

References (113)

1. L.W. Hunt, and E.C. Rosenow III Asthma-producing drugs Ann Allergy 68 1992 453 462
2. J. Van Schoor, G.F. Joos, and R.A. Pauwels Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical research Eur Respir J 16 2000 514 533
3. L.J. Roberts II, and J.D. Morrow Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout J.G. Hardman L.E. Limbird A.G. Gilman Goodman & Gilman's the pharmacological basis of therapeutics 2001 McGraw-Hill New York 687 688
4. F. Widal, P. Abrami, and J. Lermoyez First complete description of the aspirin idiosyncrasy-asthma-nasal polyposis syndrome (plus urticaria) Presse Med 18 1922 189 192
5. M. Samter, and R.F.J. Beers Intolerance to aspirin: clinical studies and consideration of its pathogenesis Ann Intern Med 68 1968 975 983
6. M. Kupczyk, I. Kuprys, and P. Gorski Aspirin intolerance and allergy to house dust mites: important factors associated with development of severe asthma Ann Allergy Asthma Immunol 92 2004 453 458
7. H. Vally, M.L. Taylor, and P.J. Thompson The prevalence of aspirin tolerant asthma (AIA) in Australian asthmatic patients Thorax 57 2002 569 574
8. C. Picado, J.A. Castillo, and J.M. Montserrat Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation Eur Respir J 2 1989 127 129
9. C.H. Marquette, F. Saulnier, and O. Leroy Long-term prognosis of near-fatal asthma Am Rev Respir Dis 146 1992 76 81
10. C. Jenkins, J. Costello, and L. Hodge Systematic review of prevalence of aspirin-induced asthma and its implications for clinical practice BMJ 328 2004 434 440
11. J.A. Namazy, and R.A. Simon Sensitivity to nonsteroidal anti-inflammatory drugs Ann Allergy Asthma Immunol 89 2002 542 550
12. L. Pang, A. Pitt, and D. Petkova The COX-1/COX-2 balance in asthma Clin Exp Allergy 28 1998 1050 1058
13. J.R. Vane Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs Nature 231 1971 232 235
14. 2 Lancet 345 1994 436 438
15. 4, and histamine in asthmatics Am Rev Respir Dis 146 1992 96 103
16. 4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects Am Rev Respir Dis 143 1991 1025 1029
17. N. Higashi, M. Taniguchi, and H. Mita Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): involvement of chronic hyperplastic rhinosinusitis with nasal polyposis J Allergy Clin Immunol 113 2004 277 283
18. K. Sladek, and A. Szczeklik Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma Eur Respir J 6 1993 391 399
19. K. Sladek, R. Dworski, and J. Soja Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge Am J Respir Crit Care Med 149 1994 940 946
20. A. Szczeklik, K. Sladek, and R. Dworski Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics Am J Respir Crit Care Med 154 1996 1608 1614
21. J.V. Bosso, L.B. Schwartz, and D.D. Stevenson Tryptase and histamine release during aspirin-induced respiratory reactions J Allergy Clin Immunol 88 1991 830 837
22. 4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma J Clin Invest 101 1998 834 846
23. 4 synthase promoter polymorphism and risk of aspirin-induced asthma Lancet 350 1997 1599 1600
24. 4 synthase: organization, nucleotide sequence, and chromosomal localization to 5q35 J Biol Chem 271 1996 11356 11361
25. 4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthma J Allergy Clin Immunol 113 2004 889 895
26. Y. Kawagishi, H. Mita, and M. Taniguchi Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma J Allergy Clin Immunol 109 2002 936 942
27. 4 synthase does not correlate wth the aspirin-intolerant asthma phenotype in the United States J Allergy Clin Immunol 106 2000 72 76
28. D.D. Stevenson, M. Sanchez-Borges, and A. Szczeklik Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes Ann Allergy Asthma Immunol 87 2001 177 180
29. A. Szczeklik, E. Nizankowska, and M. Duplaga Natural history of aspirin-induced asthma Eur Respir J 16 2000 432 436
30. M.P. Berges-Gimeno, R.A. Simon, and D.D. Stevenson The natural history and clinical characteristics of aspirin-exacerbated respiratory disease Ann Allergy Asthma Immunol 89 2002 474 478
31. E. Melillo, G. Balzano, and S. Bianco Report of the INTERASMA Working Group on standardization of inhalation provocation tests in aspirin-induced asthma: oral and inhalation provocation tests for the diagnosis of aspirin-induced asthma Allergy 56 2001 899 911
32. E. Nizankowska, A. Bestynska-Krypel, and A. Cmiel Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma Eur Respir J 15 2000 863 869
33. D.D. Stevenson, R.A. Simon, and B.L. Zuraw Sensitivity to aspirin and nonsteroidal antiinflammatory drugs E. Middleton C. Reed E. Ellis N.F. Adkinson J.W. Yunginger W.W. Busse B. Bochner F.E. Simons Allergy principles & practice 2001 Mosby St. Louis (MO) 1695 1710
34. B. Dahlen, E. Nizankowska, and A. Szczeklik Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics Am J Respir Crit Care Med 157 1998 1187 1194
35. S.-E. Dahlen, K. Malmstrom, and E. Nizankowska Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist Am J Respir Crit Care Med 165 2002 9 14
36. W. Hosemann Surgical treatment of nasal polyposis in patient with aspirin intolerance Thorax 55 Suppl 2 2000 S87 S90
37. D.D. Stevenson Approach to the patient with a history of adverse reactions to aspirin or NSAIDs: diagnosis and treatment Allergy Asthma Proc 21 2000 25 31
38. A. Szczeklik, R.J. Gryglewski, and G. Czerniawska-Mysik Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis J Allergy Clin Immunol 60 1977 276 284
39. D.D. Stevenson, A. Hougham, and P. Schrank Salsalate cross-sensitivity in aspirin-sensitive patients with asthma J Allergy Clin Immunol 86 1990 749 758
40. M. Kosnik, E. Music, and F. Matjaz Relative safety of meloxicam in NSAID-intolerant patients Allergy 53 1998 1231 1233
41. L. Andri, G. Senna, and C. Betteli Tolerability of nimesulide in aspirin-sensitive patients Ann Allergy 72 1994 29 32
42. B. Dahlen, A. Szczeklik, and J.J. Murray Celecoxib in patients with asthma and aspirin intolerance N Engl J Med 344 2001 142
43. R.A. Settipane, P. Schrank, and R.A. Simon Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects J Allergy Clin Immunol 96 1995 480 485
44. P. Gyllfors, G. Bochenek, and J. Overholt Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib J Allergy Clin Immunol 111 2003 1116 1121
45. C. Martin-Garcia, M. Hinojosa, and P. Berges Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma Chest 121 2002 1812 1817
46. D.D. Stevenson, and R.A. Simon Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma J Allergy Clin Immunol 108 2001 47 51
47. M. Sanchez-Borges, A. Capriles-Hulett, and F. Caballero-Fonsenca Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions Ann Allergy Asthma Immunol 87 2001 201 204
48. R.R. Schellenberg, and S.H. Isserow Anaphylactoid reaction to a cyclooxygenase-2 inhibitor in a patient who had a reaction to a cyclooxygenase-1 inhibitor N Engl J Med 345 2001 1856
49. D.D. Stevenson, R.A. Simon, and D.A. Mathison Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges J Allergy Clin Immunol 66 1980 82 88
50. W.W. Pleskow, D.D. Stevenson, and D.A. Mathison Aspirin desensitization in aspirin sensitive asthmatic patients: clinical manifestations and characterization of the refractory period J Allergy Clin Immunol 69 1982 11 19
51. M.P. Berges-Gimeno, R.A. Simon, and D.D. Stevenson Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease J Allergy Clin Immunol 111 2003 180 186
52. J.M. Sweet, D.D. Stevenson, and R.A. Simon Long-term effects of aspirin desensitization: treatment for aspirin-sensitive rhinosinusitis-asthma J Allergy Clin Immunol 85 1990 59 65
53. D.D. Stevenson, M.A. Hankammer, and D.A. Mathison Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes J Allergy Clin Immunol 98 1996 751 758
54. S.M. Nasser, M. Patel, and G.S. Bell The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma Am J Respir Crit Care Med 151 1995 1326 1330
55. U.R. Juergens, S.C. Christiansen, and D.D. Stevenson Inhibition of monocyte leukotriene B4 production following aspirin desensitization J Allergy Clin Immunol 96 1995 148 156
56. H.M. Krumholz, M.J. Radford, and Y.M.S. Wang National use and effectiveness of β-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project JAMA 280 1998 623 629
57. M. Okayama, N. Yafuso, and H. Nogami A new method of inhalation challenge with propranolol: comparison with methacholine-induced bronchoconstriction and role of vagal nerve activity J Allergy Clin Immunol 80 1987 291 299
58. G. Zaid, and G.N. Beall Bronchial response to beta-adrenergic blockade N Engl J Med 275 1966 580 584
59. P.J. Barnes Neural control of human airways in health and disease Am Rev Respir Dis 134 1986 1289 1314
60. P.W. Ind, C.M. Dixon, and R.W. Fuller Anticholinergic blockade of beta-blocker-induced bronchoconstriction Am Rev Respir Dis 139 1989 1390 1394
61. M. Okayama, T. Shen, and J. Midorikawa Effect of Pilocarpine on propranolol-induced bronchoconstriction in asthma Am J Respir Crit Care Med 149 1994 76 80
62. N. Crimi, F. Palermo, and R. Oliveri Effect of vasoactive intestinal peptide (VIP) on propranolol-induced bronchoconstriction J Allergy Clin Immunol 82 1988 617 621
63. G.H. Koeter, H. Meurs, and J.G. De Monchy Protective effect of disodium cromoglycate on propranolol challenge Allergy 37 1982 587 590
64. A. Foresi, A. Chetta, and A. Pelucchi Effect of inhaled disodium cromoglycate and nedocromil sodium on propranolol-induced bronchoconstriction Ann Allergy 70 1993 159 163
65. M. Fujimura, M. Abo, and Y. Kamio Effect of leukotriene and thromboxane antagoinist on propranolol-induced bronchoconstriction Am J Respir Crit Care Med 160 1999 2100 2103
66. P.W. Ind, P.J. Barnes, and M.J. Brown Plasma histamine concentration during propranolol induced bronchoconstriction Thorax 40 1985 903 909
67. G. Emilien, and J.-M. Maloteaux Current therapeutic uses and potential of β-adrenoceptor agonists and antagonists Eur J Clin Pharmacol 53 1998 389 404
68. M.H. Boskabady, and P.D. Snashall Bronchial responsiveness to beta-adrenergic stimulation and enhanced beta-blockade in asthma Respirology 5 2000 111 118
69. J.R. Carstairs, A.J. Nimmo, and P.J. Barnes Autoradiogaphic visualization of beta-adrenoceptor subtypes in human lung Am Rev Respir Dis 132 1985 541 547
70. D. Spina, P.J. Rigby, and J.W. Paterson Autoradiographic localization of beta-adrenoceptors in asthmatic human lung Am Rev Respir Dis 140 1989 1410 1415
71. A.V. Chobanian, G.L. Bakris, and H.R. Black Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 42 2003 1206 1252
72. R.B. Schoene, T.R. Martin, and N.B. Charan Timolol-induced bronchospasm in asthmatic bronchitis JAMA 245 1981 1460 1461
73. Kendall MJ. Clinical relevance of pharmacokinetic differences between beta blockers. Am J Cardiol 1997;80:15J-9.
74. A.J. Wood Pharmacologic differences between beta blockers Am Heart J 108 1984 1070 1077
75. B.B. Hoffman Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists J.G. Hardman L.E. Limbird A.G. Gilman Goodman & Gilman's the pharmacological basis of therapeutics 2001 McGraw-Hill New York 215 253
76. S.R. Salpeter, T.M. Ormiston, and E.E. Salpeter Cardioselective β-blockers in patients with reactive airway disease: a meta-analysis Ann Intern Med 137 2002 715 725
77. T.L. Dunn, M.J. Gerber, and A.S. Shen The effect of topical ophthalmic instillation of Timolol and Betaxolol on lung function in asthmatic subjects Am Rev Respir Dis 133 1986 264 268
78. F.T. Fraunfelder, and A.F. Barker Respiratory effects of Timolol N Engl J Med 311 1984 1441
79. M. Cazzola, P. Noschese, and G. D'Amato Comparison of the effects of single oral doses of nebivolol and celiprolol on airways in patients with mild asthma Chest 118 2000 1322 1326
80. National Asthma Education and Prevention Program Expert Panel Report II. Guidelines for the diagnosis and management of asthma 1997 National Heart, Lung, and Blood Institute/National Institute of Health Bethesda
81. D.J. Shulan, and M. Katlan Use of β-blockers in patients with reactive airway disease Ann Intern Med 139 2003 304
82. S.S. Gottlieb, R.J. McCarter, and R.A. Vogel Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction N Engl J Med 339 1998 489 497
83. T.J. Ryan, E.M. Antman, and N.H. Brooks 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations Circulation 100 1999 1016 1030
84. J.T. Mohammad, and A.B. Weinacker Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma Pharmacotherapy 19 1999 974 978
85. R.W. Piepho Role of angiotensin-converting-enzyme inhibition in contemporary cardiovascular therapy Am J Health Syst Pharm 57 Suppl 1 2000 S2
86. Z.H. Israili, and W.D. Hall Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy Ann Intern Med 117 1992 234 242
87. B.M. Schaefer, V. Caracciolo, and W.H. Frishman Gender, ethnicity, and genes in cardiovascular disease. Part 2: implications for pharmacotherapy Heart Dis 5 2003 202 214
88. S.R. Simon, H.R. Black, and M. Moser Cough and ACE inhibitors Arch Intern Med 152 1992 1698 1700
89. R.C. Goldszer, L.S. Lilly, and H.S. Solomon Prevalence of cough during angiotensin-converting enzyme inhibitor therapy Am J Med 85 1988 887
90. P.M. Just The positive association of cough with angiotensin-converting enzyme inhibitors Pharmacotherapy 9 1989 82 87
91. R. Wood Bronchospasm and cough as adverse reactions to the ACE inhibitors captopril, enalapril and lisinopril: a controlled retrospective cohort study Br J Clin Pharmacol 39 1995 265 270
92. J. Kaufman, S. Schmitt, and J. Barnard Angiotensin-coverting enzyme inhibitors in patients with bronchial responsiveness and asthma Chest 101 1992 922 925
93. T.J. Craig Drugs to be used with caution in patients with asthma Am Fam Physician 54 1996 947 953
94. A.J. Peacock, and A.W. Matthews The effect of captorpril on pulmonary haemodynamics and lung function in patients with chronic airflow obstruction Thorax 41 1986 225
95. C.M. Dixon, R.W. Fuller, and P.J. Barnes The effect of an angiotensin converting enzyme inhibitor, ramipril, on bronchial responses to inhaled histamine and bradykinin in asthmatic subjects Br J Clin Pharmacol 23 1987 91 93
96. L.-P. Boulet, J. Milot, and N. Lampron Pulmonary function and airway responsiveness during long-term therapy with captopril JAMA 261 1989 413 416
97. V. Popa Captopril-related (and -induced?) asthma Am Rev Respir Dis 136 1987 999 1000
98. P.F. Semple, and G.W. Herd Cough and wheeze caused by inhibitors of angiotensin-converting enzyme N Engl J Med 314 1986 61
99. N.J. Brown, and D.E. Vaughan Angiotensin-converting enzyme inhibitors Circulation 97 1998 1411 1420
100. I. Os, B. Bratland, and B. Dahlof Female sex as an important determinant of lisinopril-induced cough Lancet 339 1992 372
101. G.R. Gibson Enalapril-induced cough Arch Intern Med 149 1989 2701 2703
102. Y. Kawakami, M. Munakata, and E. Yamaguchi Molecular studies of bronchial asthma, sarcoidosis and angiotensin converting enzyme inhibitor-induced cough Respirology 3 1998 45 49
103. R.A. Dart, S. Gollub, and J. Lazar Treatment of systemic hypertension in patients with pulmonary disease Chest 123 2003 222 243
104. R.W. Fuller, and N.B. Choudry Increased cough reflex associated with angiotensin converting enzyme inhibitor cough BMJ 295 1987 1025 1026
105. S.H. Buck, and T.F. Burks Capsaicin: hot new pharmacological tool Trends Pharmacol Sci 4 1983 84 87
106. J.R. McEwan, and R.W. Fuller Angiotensin converting enzyme inhibitors and cough J Cardiovasc Pharmacol 13 Suppl 3 1989 S67 S69
107. M.G. Nicholls, and N.L. Gilchrist Sulindac and cough induced by converting enzyme inhibitors Lancet I 1987 872
108. R.W. Fuller, J.R. McEwan, and N.B. Choudry The abnormal cough reflex: role of prostaglandins Am Rev Respir Dis 139 1989 A586
109. R.W. Fuller, C.M. Dixon, and F.M. Cuss Bradykinin-induced bronchoconstriction in humans Am Rev Respir Dis 135 1987 176 180
110. H.S. Varonier, and R. Panzani The effect of inhalations of bradykinin on healthy and atopic (asthmatic) children Int Arch Allergy 34 1968 293 296
111. R. Polosa, G.D. Phillips, and C.K. Lai Contribution of histamine and prostanoids to bronchoconstriction provoked by inhaled bradykinin in atopic asthma Allergy 45 1990 174 182
112. M. Cazzola, M.G. Matera, and G. Liccardi Theophylline in the inhibition of angiotensin-converting enzyme inhibitor-induced cough Respiration (Herrlisheim) 60 1993 212 215
113. M. Hargreaves Sodium cromoglycate: a remedy for ace inhibitor-induced cough Br J Clin Pract 47 1993 319 320